Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Endothelium Progenitor Cells and Dendritic Cells as Novel Predictive Biomarkers of In-stent Restenosis After Percutaneous Coronary Intervention.

NCT00493597 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT00493597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00493597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Endothelium Progenitor Cells and Dendritic Cells as Novel Predictive Biomarkers of In-stent Restenosis After Percutaneous Coronary Intervention.
Lead sponsor
University Hospital, Antwerp
Phase
Observational
Overall status
Completed
Start date
October 31, 2007
Completion date
October 26, 2020
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, restenosis